S 652

This bill, the Protecting Patients from Deceptive Drug Ads Act, aims to regulate how prescription drugs are advertised, particularly on social media and through telehealth. It establishes penalties for false or misleading communications made by social media influencers or healthcare providers who benefit financially from these ads, requiring them to include key information about drug side effects and effectiveness. The bill also mandates reporting of payments from drug manufacturers to influencers and telehealth providers, and directs the FDA to conduct market surveillance and issue guidance on enforcement.